Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecologic cancers has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Melanoma
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Cervical Adenocarcinoma, Cervical Adenosarcoma | Phase 1 | Status: COMPLETED